Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Letter to the Editor from Rosenfield, et al: Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Rosenfield RL, Martin KA, Chang RJ, Ehrmann DA, Lobo RA, Pugeat MM. Rosenfield RL, et al. Among authors: lobo ra. J Clin Endocrinol Metab. 2024 May 29:dgae368. doi: 10.1210/clinem/dgae368. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38809759 No abstract available.
Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial.
Kantarci K, Tosakulwong N, Lesnick TG, Kara F, Kendall-Thomas J, Kapoor E, Fields JA, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Kantarci K, et al. Among authors: lobo ra. Menopause. 2024 Jan 1;31(1):10-17. doi: 10.1097/GME.0000000000002278. Epub 2023 Nov 21. Menopause. 2024. PMID: 37989141
A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life.
Gaspard U, Taziaux M, Jost M, Coelingh Bennink HJT, Utian WH, Lobo RA, Foidart JM. Gaspard U, et al. Among authors: lobo ra. Menopause. 2023 May 1;30(5):480-489. doi: 10.1097/GME.0000000000002167. Epub 2023 Feb 20. Menopause. 2023. PMID: 36809193 Free PMC article. Clinical Trial.
Challenging social media threats using collective well-being-aware recommendation algorithms and an educational virtual companion.
Ognibene D, Wilkens R, Taibi D, Hernández-Leo D, Kruschwitz U, Donabauer G, Theophilou E, Lomonaco F, Bursic S, Lobo RA, Sánchez-Reina JR, Scifo L, Schwarze V, Börsting J, Hoppe U, Aprin F, Malzahn N, Eimler S. Ognibene D, et al. Among authors: lobo ra. Front Artif Intell. 2023 Jan 9;5:654930. doi: 10.3389/frai.2022.654930. eCollection 2022. Front Artif Intell. 2023. PMID: 36699613 Free PMC article.
The 2022 hormone therapy position statement of The North American Menopause Society.
“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. “The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. Menopause. 2022 Jul 1;29(7):767-794. doi: 10.1097/GME.0000000000002028. Menopause. 2022. PMID: 35797481
Management of menopause: a view towards prevention.
Lobo RA, Gompel A. Lobo RA, et al. Lancet Diabetes Endocrinol. 2022 Jun;10(6):457-470. doi: 10.1016/S2213-8587(21)00269-2. Epub 2022 May 5. Lancet Diabetes Endocrinol. 2022. PMID: 35526556 Review.
456 results